Keros Therapeutics Statistics
Total Valuation
KROS has a market cap or net worth of $182.80 million. The enterprise value is -$61.55 million.
| Market Cap | 182.80M |
| Enterprise Value | -61.55M |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KROS has 19.62 million shares outstanding. The number of shares has decreased by -47.30% in one year.
| Current Share Class | 19.62M |
| Shares Outstanding | 19.62M |
| Shares Change (YoY) | -47.30% |
| Shares Change (QoQ) | +2.73% |
| Owned by Insiders (%) | 3.29% |
| Owned by Institutions (%) | 89.96% |
| Float | 17.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.49 |
| Forward PS | 382.59 |
| PB Ratio | 0.66 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.14, with a Debt / Equity ratio of 0.05.
| Current Ratio | 18.14 |
| Quick Ratio | 17.84 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -12.56% and return on invested capital (ROIC) is -254.67%.
| Return on Equity (ROE) | -12.56% |
| Return on Assets (ROA) | -8.36% |
| Return on Invested Capital (ROIC) | -254.67% |
| Return on Capital Employed (ROCE) | -24.10% |
| Weighted Average Cost of Capital (WACC) | 9.96% |
| Revenue Per Employee | $468,517 |
| Profits Per Employee | -$709,494 |
| Employee Count | 87 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -742,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.41% in the last 52 weeks. The beta is 1.19, so KROS's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -42.41% |
| 50-Day Moving Average | 11.11 |
| 200-Day Moving Average | 11.75 |
| Relative Strength Index (RSI) | 29.61 |
| Average Volume (20 Days) | 159,794 |
Short Selling Information
The latest short interest is 1.14 million, so 5.79% of the outstanding shares have been sold short.
| Short Interest | 1.14M |
| Short Previous Month | 1.15M |
| Short % of Shares Out | 5.79% |
| Short % of Float | 6.47% |
| Short Ratio (days to cover) | 5.91 |
Income Statement
In the last 12 months, KROS had revenue of $40.76 million and -$61.73 million in losses. Loss per share was -$2.86.
| Revenue | 40.76M |
| Gross Profit | -33.57M |
| Operating Income | -70.27M |
| Pretax Income | -62.47M |
| Net Income | -61.73M |
| EBITDA | -68.68M |
| EBIT | -70.27M |
| Loss Per Share | -$2.86 |
Balance Sheet
The company has $259.46 million in cash and $15.11 million in debt, with a net cash position of $244.35 million or $12.45 per share.
| Cash & Cash Equivalents | 259.46M |
| Total Debt | 15.11M |
| Net Cash | 244.35M |
| Net Cash Per Share | $12.45 |
| Equity (Book Value) | 279.10M |
| Book Value Per Share | 14.07 |
| Working Capital | 271.78M |
Cash Flow
In the last 12 months, operating cash flow was -$47.85 million and capital expenditures -$421,000, giving a free cash flow of -$48.27 million.
| Operating Cash Flow | -47.85M |
| Capital Expenditures | -421,000 |
| Depreciation & Amortization | 1.59M |
| Net Borrowing | n/a |
| Free Cash Flow | -48.27M |
| FCF Per Share | -$2.46 |
Margins
Gross margin is -82.36%, with operating and profit margins of -172.39% and -151.43%.
| Gross Margin | -82.36% |
| Operating Margin | -172.39% |
| Pretax Margin | -153.25% |
| Profit Margin | -151.43% |
| EBITDA Margin | -168.49% |
| EBIT Margin | -172.39% |
| FCF Margin | n/a |
Dividends & Yields
KROS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 47.30% |
| Shareholder Yield | 47.30% |
| Earnings Yield | -30.68% |
| FCF Yield | -26.36% |
Analyst Forecast
The average price target for KROS is $19.83, which is 112.88% higher than the current price. The consensus rating is "Buy".
| Price Target | $19.83 |
| Price Target Difference | 112.88% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | -43.21% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KROS has an Altman Z-Score of 5.68 and a Piotroski F-Score of 1.
| Altman Z-Score | 5.68 |
| Piotroski F-Score | 1 |